Ameriprise Financial, Inc. Acquires 5.3% Passive Stake in Palisade Bio, Inc. (PALI)

On May 15, 2026, Ameriprise Financial, Inc. (AFI) filed a Schedule 13G indicating a new substantial passive stake in Palisade Bio, Inc. (PALI). As of the event date on March 31, 2026, AFI and its subsidiary, Columbia Management Investment Advisers, LLC (CMIA), reported beneficial ownership of 8,711,385 shares of Common Stock. This position represents approximately 5.3% of the company's outstanding shares. The filing identifies AFI as a parent holding company and CMIA as an investment adviser. Both entities share voting and dispositive power over the reported shares. The acquisition was made in the ordinary course of business and not for the purpose of influencing or changing the control of the issuer. This filing marks an increase from a previous ownership level of 0.0%, establishing Ameriprise Financial as a significant institutional shareholder in the biotechnology firm. The reported value of the holdings is approximately $15.94 million based on the filing data.